Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk
- 3 March 2006
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 49 (5) , 881-890
- https://doi.org/10.1007/s00125-006-0160-4
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic SubjectsDiabetes Care, 2005
- Effects of Oral Insulin in Relatives of Patients With Type 1 DiabetesDiabetes Care, 2005
- IA-2 antibody epitopes and isotypes during the prediabetic process in siblings of children with type 1 diabetesJournal of Autoimmunity, 2004
- GAD65 antibody isotypes and epitope recognition during the prediabetic process in siblings of children with type I diabetesClinical and Experimental Immunology, 2004
- Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.Diabetes Care, 1999
- Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.Journal of Clinical Investigation, 1998
- Validity of Screening for Individuals at Risk for Type I Diabetes by Combined Analysis of Antibodies to Recombinant ProteinsDiabetes Care, 1997
- Genetic Control of Autoimmune Diabetes in the Nod MouseAnnual Review of Immunology, 1995
- Comparison of Bolus and Infusion Protocols for Determining Acute Insulin Response to Intravenous Glucose in Normal HumansDiabetes Care, 1993
- Standardization of IVGTT to Predict IDDMDiabetes Care, 1992